abstract |
The invention relates to novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis. The invention also relates to the use of these compounds as therapeutic agents and diagnostic agents, especially for treating and diagnosing neuroblastomas. In addition, the invention relates to the diagnostic agents which contain the inventive compounds. |